Fidelis Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.9M | Sell |
7,900
-55
| -0.7% | -$41K | 0.54% | 36 |
|
|
2025
Q1 | $7.04M | Buy |
7,955
+776
| +11% | +$686K | 0.75% | 30 |
|
|
2024
Q4 | $5.82M | Buy |
7,179
+236
| +3% | +$191K | 0.58% | 34 |
|
|
2024
Q3 | $6.27M | Sell |
6,943
-849
| -11% | -$767K | 0.75% | 27 |
|
|
2024
Q2 | $6.02M | Sell |
7,792
-297
| -4% | -$229K | 0.86% | 25 |
|
|
2024
Q1 | $6.29M | Buy |
8,089
+2,004
| +33% | +$1.56M | 0.96% | 22 |
|
|
2023
Q4 | $3.55M | Buy |
6,085
+1,385
| +29% | +$807K | 0.78% | 25 |
|
|
2023
Q3 | $2.52M | Buy |
4,700
+367
| +8% | +$197K | 0.86% | 20 |
|
|
2023
Q2 | $2.03M | Buy |
4,333
+224
| +5% | +$105K | 0.74% | 28 |
|
|
2023
Q1 | $1.76M | Buy |
4,109
+2,276
| +124% | +$974K | 0.75% | 27 |
|
|
2022
Q4 | $641K | Buy |
+1,833
| New | +$641K | 0.76% | 39 |
|